Final 48-Week Results of the APPLY-PNH Trial: Long-Term Efficacy & Safety in Anti-C5-Treated Patients With PNH & Persistent Anemia Undergoing Factor B Inhibition With Oral Iptacopan Monotherapy

92 views
April 3, 2024
0 Comments
Login to view comments. Click here to Login